The probiotic Companilactobacillus crustorum MN047 alleviates colitis-associated tumorigenesis via modulating the intestinal microenvironment-Reference-Cited by-同舟云学术

The probiotic Companilactobacillus crustorum MN047 alleviates colitis-associated tumorigenesis via modulating the intestinal microenvironment

Published:2021 Issue:22 Volume:12 Page:11331-11342
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Wang Tao¹,Wang Panpan¹,Ge Wupeng¹^ORCID,Shi Chao¹^ORCID,Xiao Gongnian²,Wang Xin¹,Lü Xin¹^ORCID

Affiliation:

1. College of Food Science and Engineering, Northwest Agriculture and Forestry University, Yangling, Shaanxi 712100, China

2. Zhejiang Provincial Key Lab for Biological and Chemical Processing Technologies of Farm Products, School of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou, Zhejiang 310023, China

Abstract

This study investigated the protective effect of C. crustorum MN047 on the AOM/DSS-induced CA-CRC mice, as demonstrated by the amelioration of gut barrier damage, inflammation and regulation of gut microbiota.

Funder

Chinese Universities Scientific Fund

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2021/FO/D1FO01531A

Reference41 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database